Page last updated: 2024-08-16

ribavirin and Affective Disorders

ribavirin has been researched along with Affective Disorders in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buljan, D; Gelo, J; Sakoman, LN; Sindik, I; Vrbanac, DB1
Cozzolongo, R; Giannuzzi, V; Lanzilotta, E; Leandro, G; Porcelli, P1
Anthony, DD; Bonomo, RA; Chandar, AK; Compan, A; Davitkov, P; Falck-Ytter, Y; Gideon, C; Hirsch, A; Silveira, MG; Smith, S1
Blacklaws, H; Gardner, A; Usher, K1
Fuchs, D; Schloegl, A; Schroecksnadel, S; Vogel, W; Zoller, H1
Demetrashvili, MF; Liu, S; Manatunga, A; McNutt, MD; Miller, AH; Musselman, DL; Raison, CL; Royster, EB; Woolwine, BJ1
Czarnecki, M; Gładysz, A; Inglot, M; Jańczak, G; Małyszczak, K; Pawłowski, T; Rymer, W1
Bernard, PH; Castera, L; Champbenoit, P; Constant, A; Couzigou, P; De Ledinghen, V; Demotes-Mainard, J; Henry, C1
Perry, CM; Scott, LJ1

Reviews

2 review(s) available for ribavirin and Affective Disorders

ArticleYear
Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?
    Journal of clinical nursing, 2011, Volume: 20, Issue:9-10

    Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferons; Mood Disorders; Ribavirin

2011
Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.
    Drugs, 2002, Volume: 62, Issue:3

    Topics: Adjuvants, Immunologic; Amino Acid Sequence; Anemia, Hemolytic; Antiviral Agents; Clinical Trials as Topic; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Molecular Sequence Data; Mood Disorders; Recombinant Proteins; Ribavirin

2002

Trials

3 trial(s) available for ribavirin and Affective Disorders

ArticleYear
The role of alexithymia in quality of life impairment in patients with chronic hepatitis C during antiviral treatment.
    Comprehensive psychiatry, 2015, Volume: 60

    Topics: Affective Symptoms; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Stress, Psychological

2015
Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Anemia; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Drug Tolerance; Female; Hepatitis C; Hospitalization; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Oligopeptides; Proline; Ribavirin; Severity of Illness Index; Treatment Outcome

2016
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:6

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antiviral Agents; Double-Blind Method; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Ribavirin; Time Factors; Treatment Outcome

2012

Other Studies

4 other study(ies) available for ribavirin and Affective Disorders

ArticleYear
Psychiatric aspects of hepatitis C treatment.
    Acta clinica Croatica, 2013, Volume: 52, Issue:3

    Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Mood Disorders; Ribavirin

2013
Interferon-alpha therapy in patients with hepatitis C virus infection increases plasma phenylalanine and the phenylalanine to tyrosine ratio.
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2012, Volume: 32, Issue:5

    Topics: Adult; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Female; Hepacivirus; Hepatitis, Chronic; Humans; Immunotherapy; Interferon-alpha; Male; Middle Aged; Mood Disorders; Phenylalanine; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Tyrosine; Viral Load

2012
[Neuropsychiatric disorders in HCV-infected people--own observations].
    Przeglad epidemiologiczny, 2005, Volume: 59, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Poland; Psychiatric Status Rating Scales; Quality of Life; Recombinant Proteins; Ribavirin; Severity of Illness Index; Time Factors; Treatment Outcome

2005
Impact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis C.
    Alimentary pharmacology & therapeutics, 2006, Oct-15, Volume: 24, Issue:8

    Topics: Antiviral Agents; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mood Disorders; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Failure

2006